Futura Medical Annual Report 2006
Futura Medical plc (“Futura”) develops
innovative products for the consumer
healthcare market.
Our vision is to leverage our skills and expertise to bring to market
some of the world’s most innovative consumer healthcare products.
Futura is developing a portfolio of products in sexual healthcare
and pain relief management and is evaluating further therapeutic
opportunities as potential additions to the growing pipeline. The
Company’s strategy is to out-license manufacture and distribution
to major pharmaceutical and healthcare groups.
Futura is based at the Surrey Research Park, Guildford, Surrey, and
our shares trade on the AIM market of the London Stock Exchange.
• Return on Investment: we focus on consumer
healthcare products that offer the potential for a
significant return on the costs of development.
• Over The Counter (OTC): our aim is to produce
safe and effective OTC products which are
available to consumers on a general retail basis
or through chemists without the need for a
doctor’s prescription.
• Strong Intellectual Property: we develop and
retain commercially valuable intellectual property
including know-how, patents and trademarks.
• Licensing: we aim to license our products
during their development to established
distributors who offer the best potential
commercial opportunities.
Our business strategy is centered on selecting and
developing products with regard to four elements:
